Evidence map›Paper›PMID 33707423›Full record

ArticleCell death & disease2021

Calcium channel α2δ1 subunit is a functional marker and therapeutic target for tumor-initiating cells in non-small cell lung cancer.

Yuanyuan Ma, Xiaodan Yang, Wei Zhao, Yue Yang, Zhiqian Zhang

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Calcium channels as pharmacological targets for cancer therapy.Clinical and experimental medicine · 2025
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Yuanyuan Ma *Department of Thoracic Surgery Unit II, Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, 52 Fucheng Road, Beijing, 100142, China.
Xiaodan Yang *Department of Cell Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, 52 Fucheng Road, Beijing, 100142, China.
Wei ZhaoDepartment of Cell Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, 52 Fucheng Road, Beijing, 100142, China.ORCID 0000-0001-6732-9466
Yue YangDepartment of Thoracic Surgery Unit II, Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, 52 Fucheng Road, Beijing, 100142, China. zlyangyue@bjmu.edu.cn.
Zhiqian ZhangDepartment of Cell Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, 52 Fucheng Road, Beijing, 100142, China. zlzqzhang@bjmu.edu.cn.ORCID 0000-0003-0289-2885
Peking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is hypothesized that tumor-initiating cells (TICs) with stem cell-like properties constitute a sustaining force to drive tumor growth and renew fully established malignancy. However, the identification of such a population in non-small cell lung carcinoma (NSCLC) has been hindered by the lacking of reliable surface markers, and very few of the currently available surface markers are of functional significance. Here, we demonstrate that a subpopulation of TICs could be specifically defined by the voltage-gated calcium channel α2δ1 subunit from non-small cell lung carcinoma (NSCLC) cell lines and clinical specimens. The α2δ1

Indexed as

A549 CellsAnimalsAntibodies, MonoclonalAntineoplastic Agents, ImmunologicalATP Binding Cassette Transporter, Subfamily G, Member 2Biomarkers, TumorCalcineurinCalcium Channel BlockersCalcium ChannelsCalcium SignalingCarcinoma, Non-Small-Cell LungCell ProliferationCell Self RenewalFemaleGene Expression Regulation, NeoplasticHumansABCG2 protein, humanAntibodies, MonoclonalAntineoplastic Agents, ImmunologicalATP Binding Cassette Transporter, Subfamily G, Member 2Biomarkers, TumorCACNA2D1 protein, humanCalcineurinCalcium Channel BlockersCalcium ChannelsNeoplasm ProteinsNFATC2 protein, humanNFATC Transcription FactorsNOTCH3 protein, humanReceptor, Notch3

Identifiers

PMID33707423
PMCPMC7952379
OpenAlexW3135665790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.